European Medicine Agency's data protection notice for the Interactive Regulatory Information System (IRIS)

PSUSA/00001535/202501

PSUSA/00000957/202411

Human medicines European public assessment report (EPAR): Syfovre, pegcetacoplan, Date of refusal: 16/12/2024, Status: Refused

Human medicines European public assessment report (EPAR): Elonva, corifollitropin alfa, Date of authorisation: 25/01/2010, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Teysuno, tegafur,gimeracil,oteracil, Date of authorisation: 14/03/2011, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Ristaben, sitagliptin, Date of authorisation: 15/03/2010, Revision: 30, Status: Authorised

Antimicrobial Sales and Use (ASU) Platform: Release notes

Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Date of authorisation: 05/05/2006, Revision: 36, Status: Authorised

Cyanokit